A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

Clinical trial NCT05201781 · RECRUITING

Trial details

NCT number: NCT05201781
Sponsor: Janssen Research & Development, LLC
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2022-03-09
Primary completion: 2037-07-29
Enrollment: 295

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.